- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Trinity Biotech plc (TRIB)
Trinity Biotech plc stock price live, this page displays NASDAQ TRIB stock exchange data. View the TRIB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Trinity Biotech plc real time stock price chart below.
What Is the Trinity Biotech plc Stock Price Today?
The Trinity Biotech plc stock price today is 0.670.
What Is the Stock Symbol for Trinity Biotech plc?
The stock symbol for Trinity Biotech plc is ""TRIB.""
What Stock Exchange Does Trinity Biotech plc Trade On?
Trinity Biotech plc is listed and trades on the NASDAQ stock exchange.
Is Trinity Biotech plc a Good Stock to Buy?
Determining whether Trinity Biotech plc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TRIB quote. (ISIN: US8964385046)
What Is the Trinity Biotech plc Stock Price Today?
The Trinity Biotech plc stock price today is 0.670.
What Is the Stock Symbol for Trinity Biotech plc?
The stock symbol for Trinity Biotech plc is ""TRIB.""
What Stock Exchange Does Trinity Biotech plc Trade On?
Trinity Biotech plc is listed and trades on the NASDAQ stock exchange.
Is Trinity Biotech plc a Good Stock to Buy?
Determining whether Trinity Biotech plc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TRIB quote. (ISIN: US8964385046)
NASDAQ
Currency in USD
0.670
-0.003(-0.45%)
Closed·
After Hours
0.660-0.010(-1.51%)
·
Fair Value
An estimate of a Trinity's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.640
0.670
52 wk Range
0.480
3.390
TRIB Scorecard
Full Analysis
Operates with a significant debt burden
TRIB is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Trinity's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.6400.670
52 wk Range
0.4803.390
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TRIB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Trinity's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form 6K Trinity Biotech plc For: 1 July
- Investing.com
- Form 6K Trinity Biotech plc For: 1 July
- Investing.com
- Form 6K Trinity Biotech plc For: 24 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Trinity Biotech plc Company Profile
Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic measurement of haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also provides laboratory-testing services for Sjogren’s syndrome, hearing loss, celiac disease, lupus, rheumatoid arthritis, systemic sclerosis, and other laboratory-testing services for autoimmune disorders. In addition, the company develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. It serves public health authorities, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.
Compare TRIB to Peers and Sector
Metrics to compare | TRIB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTRIBPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.4x | −10.5x | −0.5x | |
PEG Ratio | −0.01 | −0.30 | 0.00 | |
Price/Book | −0.4x | 3.2x | 2.6x | |
Price / LTM Sales | 0.2x | 4.2x | 3.2x | |
Upside (Analyst Target) | - | 39.4% | 41.2% | |
Fair Value Upside | Unlock | −0.1% | 6.2% | Unlock |
Earnings
Latest Release
May 15, 2025
EPS / Forecast
-25.58 / -0.05
Revenue / Forecast
15.86M / 17.50M
People Also Watch
FAQ
What Stock Exchange Does Trinity Trade On?
Trinity is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Trinity?
The stock symbol for Trinity is "TRIB."
What Is the Trinity Market Cap?
As of today, Trinity market cap is 12.50M.
What Is Trinity's Earnings Per Share (TTM)?
The Trinity EPS (TTM) is -1.74.
From a Technical Analysis Perspective, Is TRIB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Trinity Stock Split?
Trinity has split 2 times.
How Many Employees Does Trinity Have?
Trinity has 401 employees.
What is the current trading status of Trinity (TRIB)?
As of 29 Jul 2025, Trinity (TRIB) is trading at a price of 0.67, with a previous close of 0.67. The stock has fluctuated within a day range of 0.64 to 0.67, while its 52-week range spans from 0.48 to 3.39.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.